Comprehensive Money Management Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$601K Hold
4,706
0.39% 88
2025
Q4
$574K Buy
4,706
+160
+4% +$18.3K 0.4% 90
2025
Q3
$456K Buy
4,546
+193
+4% +$17.4K 0.32% 102
2025
Q2
$361K Sell
4,353
-289
-6% -$23.1K 0.27% 119
2025
Q1
$376K Buy
4,642
+105
+2% +$9.38K 0.3% 111
2024
Q4
$409K Buy
+4,537
New +$440K 0.34% 103

Other funds holding XBI

Comprehensive Money Management Services's XBI Position: Q1 2026 in Review

Comprehensive Money Management Services held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 4,706 shares worth $601K. The position accounts for 0.39% of the portfolio, ranked #88.

Comprehensive Money Management Services first reported a position in XBI in Q4 2024 and has held it in 6 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Comprehensive Money Management Services held 4,706 shares of State Street SPDR S&P Biotech ETF worth $601K as of Q1 2026.
  • Comprehensive Money Management Services left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.39% of Comprehensive Money Management Services's portfolio in Q1 2026, its #88 holding.
  • Comprehensive Money Management Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 6 quarters since.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Comprehensive Money Management Services's 13F filing for Q1 2026, filed 23 Apr 2026.